Filings

2 documents · 12 matches

1. PBYI PUMA BIOTECHNOLOGY, INC. 10-Q 2026-11-09

   Item 4.

   material weakness. However, the material weakness will not be considered officially remediated until the newly designed controls operate effectively for a sufficient
   11 matches in this document Show context Copy citation

2. PBYI PUMA BIOTECHNOLOGY, INC. 10-K 2026-02-26

   Item 16.

   material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk
   1 match in this document Show context Copy citation